Average Co-Inventor Count = 7.54
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Array Biopharma Inc. (27 from 329 patents)
2. Pfizer Corporation (6 from 4,455 patents)
3. Genentech, Inc. (3 from 3,223 patents)
4. Celgene Corporation (2 from 550 patents)
5. Takeda Pharmaceutical Company Limited (1 from 1,179 patents)
6. Japan Tobacco Inc. (1 from 1,040 patents)
35 patents:
1. 12447153 - HER2 mutation inhibitors
2. 12303509 - Compounds for the treatment of BRAF-associated diseases and disorders
3. 11834453 - Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors
4. 11780835 - Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinases
5. 11634409 - Compounds for the treatment of BRAF-associated diseases and disorders
6. 11414404 - Compounds for the treatment of BRAF-associated diseases and disorders
7. 11247990 - Bicyclic fused pyridine compounds as inhibitors of TAM kinases
8. 11104676 - Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinases
9. 11028093 - 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors
10. 10730880 - 4,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors
11. 10189845 - 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors
12. 10017482 - Mitotic kinesin inhibitors and methods of use thereof
13. 9499503 - Mitotic kinesin inhibitors and methods of use thereof
14. 9221841 - Mitotic kinesin inhibitors and methods of use thereof
15. 9102639 - Mitotic kinesin inhibitors and methods of use thereof